CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 2, 2021 · earnings

ACRS earnings: a negative outcome, -10.9%

On November 2, 2021, Aclaris Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -10.9% in the window around the event.

The move

$18.49
1d before
$16.48
Event day
$16.20
1d after
$16.46
5d after

Pre-catalyst setup

+0.0%
30-day run-up
4601%
30-day volatility
1.0×
volume spike